Actively Recruiting
Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening
Led by Weill Medical College of Cornell University · Updated on 2025-12-26
550
Participants Needed
5
Research Sites
169 weeks
Total Duration
On this page
Sponsors
W
Weill Medical College of Cornell University
Lead Sponsor
M
Myriad Genetics, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators hypothesize that pregnancy and preconception care may be a feasible and effective time to offer inherited cancer risk screening. This study will assess interest in cancer genetic testing among patients receiving routine prenatal or preconception/fertility care. The goal is to evaluate the acceptability of BRCA1/2 testing when offered alongside standard prenatal genetic screening. The study will also explore whether universal screening in this population could support early cancer prevention and be cost-effective, especially among underserved populations.
CONDITIONS
Official Title
Trial of Combined Obstetric Carrier Screening and Hereditary Cancer Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years - 55 years
- Pregnant patients receiving obstetrical-related care or receiving preconception/fertility care at a WCM-affiliated enrollment site
- Patients who have elected to undergo OCS with the WCM-affiliated obstetrics provider
- Patients with prior OCS but planned to repeat OCS are eligible
- Patients can speak and read in English or Spanish
You will not qualify if you...
- Patients who have previously completed a multigene hereditary cancer syndrome panel
- Patients who have a hematologic cancer or hematologic pre-cancer
- Patients who have a history of an autologous bone marrow transplant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Reproductive Medicine
Brooklyn, New York, United States, 11201
Actively Recruiting
2
NewYork-Presbyterian Weill Cornell Medicine
Brooklyn, New York, United States, 11215
Not Yet Recruiting
3
Reproductive Medicine
New York, New York, United States, 10021
Actively Recruiting
4
Weill Cornell Medicine
New York, New York, United States, 10065
Actively Recruiting
5
NewYork-Presbyterian Weill Cornell Medicine Queens
Queens, New York, United States, 11355
Actively Recruiting
Research Team
S
Steve Lopez, BA
CONTACT
R
Ravi Sharaf, MD, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here